Literature DB >> 21088295

Local renal autoantibody production in lupus nephritis.

Marion Espeli1, Susanne Bökers, Giovanna Giannico, Harriet A Dickinson, Victoria Bardsley, Agnes B Fogo, Kenneth G C Smith.   

Abstract

Autoantibodies are central to the pathogenesis of several autoimmune diseases including systemic lupus erythematosus. Plasma cells secrete these autoantibodies, but the anatomical sites of these cells are not well defined. Here, we found that although dsDNA-specific plasma cells in NZB/W mice were present in spleen and bone marrow, a large number were in the kidneys and their number correlated with the serum dsDNA-IgG titer. We observed renal plasma cells only in mice with nephritis, where they located mainly to the tubulointerstitium of the cortex and outer medulla. These cells had the phenotypic characteristics of fully differentiated plasma cells and, similar to long-lived bone marrow plasma cells, they were not in cell cycle. In patients with lupus nephritis, plasma cells were often present in the medulla in those with the most severe disease, especially combined proliferative and membranous lupus nephritis. The identification of the kidney as a major site of autoreactive plasma cells has implications for our understanding of the pathogenesis of lupus nephritis and for strategies to deplete autoreactive plasma cells, a long-standing therapeutic aim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088295      PMCID: PMC3029902          DOI: 10.1681/ASN.2010050515

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

1.  FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.

Authors:  Zou Xiang; Antony J Cutler; Rebecca J Brownlie; Kirsten Fairfax; Kate E Lawlor; Eva Severinson; Elizabeth U Walker; Rudolf A Manz; David M Tarlinton; Kenneth G C Smith
Journal:  Nat Immunol       Date:  2007-02-18       Impact factor: 25.606

2.  SDF-1 expression is elevated in chronic human renal allograft rejection.

Authors:  U Hoffmann; B Banas; B Krüger; M Banas; T Bergler; C Böger; M Kammerl; A Obed; P Rümmele; S Segerer; G A J Riegger; B K Krämer
Journal:  Clin Transplant       Date:  2006 Nov-Dec       Impact factor: 2.863

3.  Expression of SDF-1/CXCR4 in injured human kidneys.

Authors:  Danny Lotan; Natalia Sheinberg; Jury Kopolovic; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2007-10-31       Impact factor: 3.714

4.  The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury.

Authors:  Li Li; Liping Huang; Sun-Sang J Sung; Amy L Vergis; Diane L Rosin; C Edward Rose; Peter I Lobo; Mark D Okusa
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

5.  The abnormal high expression of B cell activating factor belonging to TNF superfamily (BAFF) and its potential role in kidney transplant recipients.

Authors:  Haiyan Xu; Xiaozhou He; Qing Liu; Yingdi Chen; Yibei Zhu; Dan Shi; Xueguang Zhang
Journal:  Cell Mol Immunol       Date:  2008-12       Impact factor: 11.530

6.  The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.

Authors:  Marguerite E Hill; Hiroyuki Shiono; John Newsom-Davis; Nick Willcox
Journal:  J Neuroimmunol       Date:  2008-08-22       Impact factor: 3.478

7.  Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.

Authors:  S Morimoto; S Nakano; T Watanabe; Y Tamayama; A Mitsuo; Y Nakiri; J Suzuki; K Nozawa; H Amano; Y Tokano; T Kobata; Y Takasaki
Journal:  Rheumatology (Oxford)       Date:  2007-05-11       Impact factor: 7.580

8.  Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab.

Authors:  Alastair J Ferraro; Mark T Drayson; Caroline O S Savage; Ian C M MacLennan
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

Review 9.  A review of the current use of rituximab in autoimmune diseases.

Authors:  Hakan M Gürcan; Derin B Keskin; Joel N H Stern; Matthew A Nitzberg; Haris Shekhani; A Razzaque Ahmed
Journal:  Int Immunopharmacol       Date:  2008-11-08       Impact factor: 4.932

10.  High affinity germinal center B cells are actively selected into the plasma cell compartment.

Authors:  Tri Giang Phan; Didrik Paus; Tyani D Chan; Marian L Turner; Stephen L Nutt; Antony Basten; Robert Brink
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

View more
  51 in total

Review 1.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

Review 2.  Immunopathology of lupus nephritis.

Authors:  Hans-Joachim Anders; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

3.  Renal cocktail: too hard for a diabetic.

Authors:  Ankur Gupta; Mohan Biyani; Susan J Robertson
Journal:  Int Urol Nephrol       Date:  2011-07-22       Impact factor: 2.370

Review 4.  Ectopic lymphoid neogenesis in rheumatic autoimmune diseases.

Authors:  Michele Bombardieri; Myles Lewis; Costantino Pitzalis
Journal:  Nat Rev Rheumatol       Date:  2017-02-09       Impact factor: 20.543

5.  Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.

Authors:  Ying-Yu Wu; Ina Georg; Alejandro Díaz-Barreiro; Nieves Varela; Bernard Lauwerys; Ramesh Kumar; Harini Bagavant; Mireia Castillo-Martín; Fadi El Salem; Concepción Marañón; Marta E Alarcón-Riquelme
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

Review 6.  Plasma cells as an innovative target in autoimmune disease with renal manifestations.

Authors:  Falk Hiepe; Andreas Radbruch
Journal:  Nat Rev Nephrol       Date:  2016-02-29       Impact factor: 28.314

Review 7.  A novel pathogenetic concept-antiviral immunity in lupus nephritis.

Authors:  Adriana Migliorini; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

8.  Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.

Authors:  Rita Kansal; Noah Richardson; Indira Neeli; Saleem Khawaja; Damian Chamberlain; Marium Ghani; Qurat-Ul-Ain Ghani; Louisa Balazs; Sarka Beranova-Giorgianni; Francesco Giorgianni; James N Kochenderfer; Tony Marion; Lorraine M Albritton; Marko Radic
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

9.  Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.

Authors:  Wensheng Wang; Javier Rangel-Moreno; Teresa Owen; Jennifer Barnard; Sarah Nevarez; H Travis Ichikawa; Jennifer H Anolik
Journal:  J Immunol       Date:  2014-02-26       Impact factor: 5.422

Review 10.  Plasma cells in immunopathology: concepts and therapeutic strategies.

Authors:  Benjamin Tiburzy; Upasana Kulkarni; Anja Erika Hauser; Melanie Abram; Rudolf Armin Manz
Journal:  Semin Immunopathol       Date:  2014-04-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.